ONC ONC
Company Profile ↓Company Overview
ONC (ONC) is a publicly traded company listed on with a market capitalization of $504.72B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 82.5% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.25.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $5.34B (+40.2% YoY); net profit $286.93M.
- Trailing 12 Months Year-on-year growth — revenue +40.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 82.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 82.50% |
| 1 Year: | 40.23% |
Stock Price Performance
| 1 Year: | +7.63% |
| 6 Months: | -5.44% |
| 3 Months: | +10.10% |
| 1 Month: | +6.01% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)63.10 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 82.5% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 132.6.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 0 | 0 | 220.21M | 18.17M | 32.54M | 52.80M | 54.20M | 58.67M | 77.83M | 243.35M | 50.14M | 56.89M | 52.06M | 65.64M | 91.08M | 100.10M | 605.87M | 149.99M | 206.44M | 306.63M | 341.57M | 387.63M | 447.80M | 595.26M | 781.31M | 751.65M | 929.17M | 1.00B | 1.12B | 1.32B | 1.41B | 1.50B | 1.51B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 165.00M | 164.61M | 196.51M | 142.42M | 167.22M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 366.01M | 499.27M | 685.00M | 626.72M | 791.03M | 831.14M | 952.28M | 1.15B | 1.22B | 1.36B | 1.35B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 941.17M | 1.06B | 1.05B | 1.17B | 1.10B |
| Operating Income | -6.57M | -13.99M | -26.38M | -20.33M | -24.63M | -34.83M | -37.27M | -51.54M | -58.02M | 114.91M | -103.80M | -110.81M | -163.05M | -151.10M | -280.81M | -173.75M | -85.83M | -312.27M | -388.04M | -373.76M | -358.88M | -440.14M | -484.91M | 70.17M | -474.84M | -462.32M | -443.29M | -439.40M | -438.36M | -371.26M | -318.71M | -133.97M | -261.35M | -107.16M | -120.27M | 11.10M | 87.89M | 163.11M | 185.03M | 249.90M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 60.71M | 123.50M | 200.40M | 248.97M | 333.25M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.00M | - | - | - | 32.89M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.90M | 99.55M | 147.16M | 149.24M | 259.21M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.63M | 5.23M | 22.32M | 82.74M | 31.86M |
| Net Income | -5.64M | -14.00M | -27.25M | -22.00M | -24.12M | -35.49M | -37.60M | -50.62M | -60.55M | 117.39M | -99.32M | -104.60M | -156.89M | -144.03M | -268.25M | -167.64M | -85.57M | -307.36M | -388.06M | -363.74M | -335.20M | -425.22M | -472.75M | 66.50M | -480.34M | -438.11M | -435.20M | -565.73M | -557.56M | -348.43M | -381.14M | 215.41M | -251.15M | -120.41M | -121.35M | 1.27M | 94.32M | 124.84M | 66.50M | 227.36M |
| Diluted EPS | - | - | - | - | - | -0.08 | - | -0.10 | -0.12 | 0.20 | -0.17 | - | - | -0.19 | - | - | - | - | - | -0.36 | - | - | - | 0.05 | -0.40 | -0.36 | -0.33 | -0.42 | -0.41 | -0.26 | -0.28 | 0.15 | -0.19 | -0.09 | -0.09 | 0.00 | 0.78 | 1.04 | 0.52 | 1.95 |
| R&D Expense | 6.74M | 13.35M | - | 17.88M | 21.12M | 30.11M | - | 42.77M | 47.24M | 87.66M | - | 109.70M | 164.25M | 147.59M | - | 178.35M | 228.76M | 236.97M | - | 304.30M | 285.97M | 349.07M | - | 320.73M | 356.09M | 351.94M | 389.92M | 378.21M | 426.36M | 408.58M | 422.76M | 453.26M | 460.64M | 454.47M | 496.18M | 481.89M | 524.90M | 523.66M | - | 541.22M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.04M | 8.82M | 1.07M | 238.39M | 198.22M | 428.21M | 308.87M | - | 1.42B | 2.46B | 3.81B | 5.34B |
| Cost of Revenue | - | - | - | - | - | - | - | - | 286.48M | 379.92M | 594.09M | 668.54M |
| Gross Profit | - | - | - | - | - | - | - | - | 1.13B | 2.08B | 3.22B | 4.67B |
| Operating Expenses | - | - | - | - | - | - | - | - | 2.92B | 3.29B | 3.78B | 4.23B |
| Operating Income | -15.76M | -56.74M | -117.06M | -98.46M | -705.77M | -959.89M | -1.66B | - | -1.79B | -1.21B | -568.20M | 447.14M |
| EBITDA | - | - | - | - | - | - | - | - | -1.72B | -733.80M | -339.43M | 616.77M |
| Interest Expense | - | - | - | - | - | - | - | - | - | 4.36M | 21.80M | 58.23M |
| Pretax Income | - | - | - | - | - | - | - | - | -1.96B | -825.84M | -533.00M | 416.85M |
| Tax Provision | - | - | - | - | - | - | - | - | 42.78M | 55.87M | 111.78M | 129.92M |
| Net Income | -18.28M | -57.10M | -119.22M | -93.11M | -673.77M | -948.63M | -1.62B | - | -2.00B | -881.71M | -644.79M | 286.93M |
| Diluted EPS | - | - | - | - | - | -1.22 | -1.50 | - | -19.37 | -8.45 | -6.12 | 2.47 |
| R&D Expense | 21.86M | 58.25M | 98.03M | 269.02M | 679.00M | 927.34M | 1.29B | 1.46B | 1.64B | 1.78B | 1.95B | 2.15B |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 116.76M | 405.81M | 1.05B | 2.25B | 1.61B | 5.60B | - | 6.38B | 5.81B | 5.92B | 8.19B |
| Current Assets | - | - | - | - | - | - | - | - | - | 5.21B | 4.20B | 3.99B | 6.23B |
| Cash & Equivalents | 3.93M | 13.90M | 17.87M | 87.51M | 239.60M | 712.94M | 618.01M | 1.38B | - | 3.87B | 3.17B | 2.63B | 4.55B |
| Inventory | - | - | - | - | - | - | - | - | - | 282.35M | 416.12M | 494.99M | 608.23M |
| Receivables | - | - | - | - | - | - | - | - | - | 173.17M | 358.03M | 676.28M | 865.08M |
| Total Liabilities | - | - | 42.45M | 52.91M | 362.25M | 496.04M | 633.93M | 1.73B | - | 2.00B | 2.27B | 2.59B | 3.83B |
| Current Liabilities | - | - | 35.17M | 35.06M | 149.99M | 246.45M | 310.31M | 1.08B | - | 1.47B | 1.81B | 2.21B | 1.83B |
| Long Term Debt | - | - | - | 17.28M | 9.22M | 40.78M | 83.31M | 183.64M | - | 209.15M | 197.62M | 166.48M | 961.91M |
| Total Debt | - | - | - | - | - | - | - | - | - | 596.67M | 930.18M | 1.08B | 1.09B |
| Total Equity | -36.96M | -53.04M | -101.77M | 352.91M | 669.81M | 1.74B | 962.21M | 3.87B | - | 4.38B | 3.54B | 3.33B | 4.36B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | 1.36B | 1.35B | 1.38B | 1.54B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -39.84M | -89.51M | 12.75M | -547.72M | -750.27M | -1.28B | - | -1.50B | -1.16B | -140.63M | 1.13B |
| Investing Cash Flow | - | -58.91M | -221.85M | -356.32M | -637.61M | 554.16M | -3.17B | - | 1.08B | 60.00M | -548.35M | -276.15M |
| Financing Cash Flow | - | 103.20M | 380.90M | 490.36M | 1.69B | 85.68M | 5.20B | - | -18.97M | 416.48M | 193.45M | 1.06B |
| Capital Expenditure | -654.00K | -5.31M | -23.50M | -46.37M | -70.28M | -89.61M | -117.51M | - | -469.10M | -596.26M | -529.14M | -266.53M |
| Free Cash Flow | - | -45.16M | -113.02M | -33.62M | -618.00M | -839.88M | -1.40B | - | -1.97B | -1.75B | -669.77M | 861.05M |
| Net Change in Cash | - | - | - | - | - | - | - | - | -438.47M | -680.97M | -495.53M | 1.91B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 79.8% | 84.5% | 84.4% | 87.5% |
| Operating Margin % | -120.9% | -643.7% | -10,940.2% | -41.3% | -356.1% | -224.2% | -536.7% | - | -126.4% | -49.1% | -14.9% | 8.4% |
| Net Margin % | -140.2% | -647.7% | -11,141.8% | -39.1% | -339.9% | -221.5% | -526.1% | - | -141.5% | -35.9% | -16.9% | 5.4% |
| ROE % | 34.5% | 56.1% | -33.8% | -13.9% | -38.7% | -98.6% | -42.0% | - | -45.7% | -24.9% | -19.4% | 6.6% |
| ROCE % | - | -69.5% | -31.6% | -11.0% | -35.2% | -73.7% | -36.6% | - | -36.4% | -30.2% | -15.3% | 7.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ONC
Assurant Inc. stock outperforms competitors on strong trading day - MarketWatch
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPU3JXdkE4WHVfOG9xWXRPZHRCcV8xR05kcDB5bE51LUhUQngwbGFqWWxPMVpzNmlhZkxCbUh5a3RIdVNCOWNndEk3ajdzVEVDUmlXT2V5NmdSbXpCTV93SmNOaDBDdDRncDBHLWFQdWdzYnRINTl1dkpzaGNyaW9nMGJpUW92VWdNZDZKb1…
BeOne's BEQALZI gets FDA accelerated approval for relapsed mantle cell lymphoma - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQUTJUZ1N3REh2MUVkRGhucXNDRVR4ZmpwdGlocG5ELU94aWdHN2g0dTRBajlNeUpRS1JMVFVDRkIyazZXMkdHQ3VnX0VlWGVNV0E5T0ZLU3hYWGlBMnZ4bkplZG52clVBM0hHTk5iam5MRTQ4c3RYdHg5dDlteGNIcXNMMmRUMTVCQWtlZF…
Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis - TradingKey
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOQlNGcWRjX0RfWHJYeEZzaE5WY1pHRDZ6Y3plbXdGYi1aY0JtRTB3ang3bmd6MlZDMnRpSlFPNWVjNVlRTWtxdEdEd05pOF95NXplREhwek40RWFscGtnMVR1cnFZN0tqcXNJTVVvLW1zVVYwdUh0dnJOTHJiUERDNVBEWEZCUDd3ZVJr?o…
Why Gartner Inc. Stock Is Soaring Today - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxQa2d0aFlxaFZNaVRMbzRNVG1mcG5fcG5FOEVUeHc5bVRrY2FPQjFsSnpoSUdHRzNEZjdra2ZTLU5tNFpfdUdSS0lsMUFpYTUyejNrVjJIeDE3SmxhRkQycmxzVlY2SnNrT0U0bzFPS09ZLVN0N3phcmNfTGtaSXg5aE9DWkk0bm1V?oc=5"…
Booking Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxORDFIWEdEcndDdkhlQ0J4Y2txc2lqVlI5eklrdkZzZG9EVHg0Wmota3FoaFlGd3psMGhDY1Jyb2liakdjY1RGdG5SM1VrbFV3VG1tUmo0aHJxdERwdzR2ZXh5dVVzZlN6bUJUUmR6elJpeWgwS2J6ZDJHa3FXSEplRHZuYXA0UkRONmZVQ0…
Qualcomm Inc Stock (QCOM) Moved Down by 3.31% on Aug 5: Key Drivers Unveiled - TradingKey
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOODRWWHJkZkVrbm1CTUh5emdMV2FmQk5CN2R4eTR6ZXhKejVCRldfLWdMQTVaYTQwTGs1Nk5KaWJMZmMycENzMXVoMl80a0M2cUdKQ0NiVmJWNUp5ZnRyVXRKWHRNeVV6Z0FBMlpoaF85ci1aQ1NwM0gwZEc0YzJjX0xnakVHU0Fydkx3?o…
ONC — Frequently Asked Questions
What is the current share price of ONC?
As of 2026-08-05 17:25 PDT, ONC trades at $327.53 on NASDAQ/NYSE. Its 52-week range is $260.27 to $377.47.
What is the market capitalisation of ONC?
ONC has a market capitalisation of $504.72B on NASDAQ/NYSE.
What is the P/E ratio of ONC?
ONC trades at a trailing price-to-earnings (P/E) ratio of 132.60. Its price-to-book (P/B) ratio is 115.73.
What is the return on equity (ROE) of ONC?
ONC has a return on equity (ROE) of 6.58%. Its return on capital employed (ROCE) is 7.03%.
Is ONC a good stock to buy?
This page provides a data-driven analysis of ONC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.